321 related articles for article (PubMed ID: 17763696)
21. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
[TBL] [Abstract][Full Text] [Related]
22. Accuracy of endobronchial ultrasound guided-transbronchial needle aspiration in mediastinal lymph node diagnosis.
Bangpattanasiri K; Sangsayunh P; Panjapornpon K; Wichitsanguan C
J Med Assoc Thai; 2012 Aug; 95 Suppl 8():S19-23. PubMed ID: 23130470
[TBL] [Abstract][Full Text] [Related]
23. Metastatic prostatic adenocarcinoma mimicking inflammatory breast carcinoma: a case report.
Njiaju UO; Truica CI
Clin Breast Cancer; 2010 Feb; 10(1):E3-5. PubMed ID: 20133250
[TBL] [Abstract][Full Text] [Related]
24. Carcinoma erysipeloides from prostate cancer presenting as cellulitis.
Ng CS
Cutis; 2000 Apr; 65(4):215-6. PubMed ID: 10795081
[TBL] [Abstract][Full Text] [Related]
25. Prostate cancer metastatic to the stomach.
Christoph F; Grünbaum M; Wolkers F; Müller M; Miller K
Urology; 2004 Apr; 63(4):778-9. PubMed ID: 15072903
[TBL] [Abstract][Full Text] [Related]
26. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
Stock RG; Stone NN; Ianuzzi C; Unger P
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
[TBL] [Abstract][Full Text] [Related]
27. [Rational lymph node dissection for lung cancer according to the occurrence lobe and histological type].
Ota S; Inaba H; Yoshida H
Kyobu Geka; 2001 Dec; 54(13):1073-8; discussion 1078-81. PubMed ID: 11761888
[TBL] [Abstract][Full Text] [Related]
28. [CT guided percutaneous needle biopsy of mediastinal lymph nodes for staging of primary lung carcinoma].
Akamatsu H; Amano J; Suzuki A; Kikushima Y
Kyobu Geka; 1994 Jun; 47(6):462-5. PubMed ID: 8207886
[TBL] [Abstract][Full Text] [Related]
29. Comparison of proliferating cell nuclear antigen immunostaining in lymph node metastases and primary prostate adenocarcinoma after neoadjuvant androgen deprivation therapy.
Minardi D; Galosi AB; Giannulis I; Montironi R; Polito M; Muzzonigro G
Scand J Urol Nephrol; 2004; 38(1):19-25. PubMed ID: 15204422
[TBL] [Abstract][Full Text] [Related]
30. Lymph node metastases of prostatic adenocarcinoma in the mesorectum in patients with adenocarcinoma or villous tumor of the rectum with collision phenomenon in a single lymph node: report of five cases.
Mourra N; Parc Y; McNamara D; Tiret E; Flejou JF; Parc R
Dis Colon Rectum; 2005 Feb; 48(2):384-9. PubMed ID: 15812588
[TBL] [Abstract][Full Text] [Related]
31. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
32. [Prostatic cancer with cystic formation: a case report].
Takayama H; Arai Y; Meguro N; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
Hinyokika Kiyo; 1996 Dec; 42(12):977-80. PubMed ID: 9013236
[TBL] [Abstract][Full Text] [Related]
33. 10-year survival of a patient with metastatic prostate cancer: Case report and literature review.
Krpina K; Markić D; Rahelić D; Ahel J; Rubinić N; Španjol J
Arch Ital Urol Androl; 2015 Sep; 87(3):252-3. PubMed ID: 26428652
[TBL] [Abstract][Full Text] [Related]
34. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
[TBL] [Abstract][Full Text] [Related]
35. Prostate carcinoma metastatic to the cervical lymph nodes: report of two cases and review of the literature.
Copeland B; Clark JM; Sura A; Kilpatrick SE; Shockley W; Meredith S
Am J Otolaryngol; 2001; 22(6):420-3. PubMed ID: 11713729
[TBL] [Abstract][Full Text] [Related]
36. Metastatic prostate cancer masquerading clinically and radiologically as a primary caecal carcinoma.
Kabeer MA; Lloyd-Davies E; Maskell G; Hohle R; Mathew J
World J Surg Oncol; 2007 Jan; 5():2. PubMed ID: 17207288
[TBL] [Abstract][Full Text] [Related]
37. [Neuroendocrine carcinoma of the prostate effectively treated by cisplatin and irinotecan--a case report].
Inoue S; Oka K; Araki T; Yano A; Tacho T; Fujii M; Kimoto K; Murakami M; Ohshiro Y
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1323-5. PubMed ID: 17687224
[TBL] [Abstract][Full Text] [Related]
38. [A case of completely responding stage D2 prostatic cancer with no evidence of disease 14 years after diagnosis].
Tsuzuki M; Kawakami S; Yonese J; Ueda T; Kageyama S; Yamauchi T; Kawai T
Hinyokika Kiyo; 1994 Sep; 40(9):837-40. PubMed ID: 7801848
[TBL] [Abstract][Full Text] [Related]
39. Cervical lymph node enlargement on the right side as the initial manifestation of metastatic prostate cancer.
Ozgür A; Ilker Y; Türkeri LN
Arch Esp Urol; 2003 Sep; 56(7):859-61. PubMed ID: 14595895
[TBL] [Abstract][Full Text] [Related]
40. Metastatic, sarcomatoid, and PSA- and PAP-negative prostatic carcinoma: diagnosis by fine-needle aspiration.
Renshaw AA; Granter SR
Diagn Cytopathol; 2000 Sep; 23(3):199-201. PubMed ID: 10945910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
